Shares of Health Care sector company Bio-Techne Corp moved 0.8% today, and are now trading at a price of $59.23. The Mid-Cap stock's daily volume was 1,534,256 compared to its average volume of 2,323,021. The S&P 500 index returned a -0.0% performance.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company is based in Minneapolis and has 3,100 full time employees. Its market capitalization is $9,285,309,440. Bio-Techne Corp currently offers its equity investors a dividend that yields 0.5% per year.
14 analysts are following Bio-Techne Corp and have set target prices ranging from $51.0 to $80.0 per share. On average, they have given the company a rating of buy. At today's prices, TECH is trading -10.26% away from its average analyst target price of $66.0 per share.
Over the last year, TECH shares have gone down by -26.3%, which represents a difference of -43.2% when compared to the S&P 500. The stock's 52 week high is $83.62 per share and its 52 week low is $46.01. With average free cash flows of $225.03 Million that have been growing at an average rate of 8.8% over the last 5 years, Bio-Techne Corp declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 298,981 | 62,877 | 236,104 | 9.23 |
| 2023 | 254,393 | 38,244 | 216,149 | -22.9 |
| 2022 | 325,272 | 44,908 | 280,364 | -8.93 |
| 2021 | 352,164 | 44,301 | 307,863 | 100.6 |
| 2020 | 205,217 | 51,744 | 153,473 | -1.75 |
| 2019 | 181,619 | 25,411 | 156,208 |
